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Abstract
Background: Cervical ripening is an inflammatory reaction. The glucocorticoid receptor (GR) mediates glucocorticoid anti-
inflammatory reactions, whereas nuclear factor (NF)kappaB is a key pro-inflammatory transcription factor. Prostaglandins as
well as platelet activating factor (PAF) are inflammatory mediators. Inducible nitric oxide synthase (iNOS) regulates the level of
nitric oxide (NO) in response to various inflammatory stimuli. We hypothesize that a changed biological response to
glucocorticoids could be a mechanism regulating the inflammatory events resulting in cervical ripening.
Methods: We monitored GR and NFkappaB, prostaglandin synthases cyclooxygenase (COX)-1 and -2, iNOS, as well as the
PAF-receptor (PAF-R) in the uterine cervix from term pregnant women (with unripe cervices) before the onset of labor (TP),
immediately after parturition (PP), as compared to non-pregnant (NP), using immunohistochemistry and RT-PCR.
Results: The GR protein was detected by immunohistochemistry in the nuclei of stroma and squamous epithelium (SQ).
Stromal GR staining was increased in TP as compared to the NP group and decreased again after parturition. GR staining in SQ
was decreased after parturition as compared to term. NFkappaB was present in SQ and glandular epithelium (GE), stroma and
vascular endothelium. Increased nuclear NFkappaB staining was observed postpartum as compared to term pregnancy in stroma
and GE. Stromal immunostaining for COX-1 as well as COX-2 was increased in the TP and PP groups as compared to the NP,
and GE displayed an intensely increased COX-2 immunostaining at term and postpartum. Stromal PAF-R immunostaining was
highest at term, while it was greatly increased in GE postpartum.
No difference in the immunostaining for iNOS was found between the groups. RT-PCR showed a predominance of GRalpha to
GRbeta mRNA in cervical tissue. The COX-2 mRNA level was increased in the PP group as compared to the TP group.
Conclusions: There is a decrease in GR levels in human cervix at parturition. Concomitantly there is an increase of factors
such as NFkappaB, PAF-R, COX-1 and COX-2, suggesting that they may participate in the sequence of events leading to the
final cervical ripening.
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Background
The human uterine cervix undergoes biochemical changes
resulting in softening, effacement and dilatation during
pregnancy and labor. This remodeling, or ripening, is a
prerequisite for parturition [1]. It is characterized by
inflammatory events, such as extravasation of neutrophils
and macrophages [2,3] and an increased cervical level of
pro-inflammatory cytokines such as interleukin (IL)-8
[3,4]. Progesterone, essential for the maintenance of preg-
nancy, and glucocorticoids have anti-inflammatory prop-
erties [5]. Placental production of progesterone and
adrenal synthesis of glucocorticoids [6] increase markedly
during human pregnancy. The antiprogestin (RU486),
successful for labor induction at term in humans [7], also
has anti-glucocorticoid properties. Progesterone and cor-
tisol regulate the human placental corticotropin-releasing
hormone (CRH) gene [8]. Placental CRH, synthesized in
abundance in the human placental syncytiotrophoblasts
and trophoblasts [9], has been proposed to be a key regu-
lator for human parturition trough interactions with adre-
nal steroids and estrogen [10].
Among the group of structurally related, ligand-inducible
nuclear steroid receptor transcription factor proteins, GR
was the first that was cloned and sequenced [11]. GR and
the progesterone receptor (PR) share structural similari-
ties, and they interact with the same hormone responsive
elements [12]. The GRα and GRβ isoforms are derived
from the same gene, and GRα is the major form found in
human cells and tissues [13].
NFκB is a key pro-inflammatory regulator. GR and NFκB
are both inducible transcription factors with diametrically
opposed functions in inflammatory responses. A mutual
negative direct and indirect cross talk between GR and
NFκB has been well described in previous studies [5,14].
Prostaglandin E2 (PGE2) is widely implicated for cervical
ripening in clinical practice [15]. Among the COX
enzymes, regulating prostaglandin synthesis, the COX-1
form is constitutively expressed, whereas COX-2 is induc-
ible and particularly involved in inflammatory events
[16]. The COX enzymes are down regulated by cortisol in
human decidua, myometrium and cervix [17].
Platelet-activating factor (PAF) is a lipid pro-inflamma-
tory mediator, involved in several reproductive processes,
i.e. parturition [18]. PAF is synthesized by some leuko-
cytes, blood platelets and vascular endothelial cell [19].
The PAF receptor (PAF-R) is a G-coupled membrane
receptor with an estrogen responsive element within its
promoter region, enabling regulation by estrogens [20].
The activation of PAF-R is associated with cytoskeletal
remodeling and expression of pro-inflammatory modula-
tors, such as COX-2, IL-6 and IL-8 [21]. Thus, PAF-R and
COX enzymes have been widely demonstrated as factors
involved in the events promoting and proceeding parturi-
tion, yet their cell origin in the human uterine cervix
remains to be clarified.
Nitric oxide (NO) is synthesized intracellularly from the
amino acid L-arginine through the activity of specific syn-
thase enzymes (NOS) [22]. The inducible form, iNOS,
present in e.g. macrophages, regulates the level of NO in
response to various inflammatory stimuli, including
proinflammatory cytokines and lipopolysaccharides.
NO stimulates PGE2 release from human cervical tissue
explants [23], and is a powerful regulator of COX-2
thereby increasing local PGE2 concentrations in inflam-
matory tissues [24,25]. NO donors do induce cervical rip-
ening in human pregnancy in the first trimester [26,27], at
term [28] and in non-pregnant women [29]. Besides,
treatment with the NO donor isosorbide-5-mononitrate
stimulates production of e.g. COX-2 and PGE2 in human
cervix [27]. The action of NO on cervical ripening appears
to be accomplished by effects on connective tissue and
smooth muscle cells in a similar way as previously been
shown for prostaglandins [27].
Our hypothesis is that glucocorticoids exert a direct recep-
tor mediated effect in the human cervix uteri, and that a
changed biological response to glucocorticoids could be a
mechanism behind the events resulting in cervical ripen-
ing at parturition. Since NFκB has opposed functions in
inflammatory responses as compared to GR, we presume
that NFκB could also be a regulator of the inflammatory
events leading to cervical ripening. These inflammatory
events could be mediated via factors such as the PAF-R,
iNOS and/or COX enzymes.
Methods
Study patients
All women gave their informed consent and the Local Eth-
ics Committee of the Karolinska Hospital approved the
study. All were healthy, had uncomplicated pregnancies
and were without medication prior to parturition. The
non-pregnant (NP) women were hysterectomised due to
benign disorders not involving the cervix. The women in
the term pregnant (TP) group all had unripe cervices with
a Bishop score <5 points and none of them were in labor.
Biopsies were obtained during elective caesarean sections
before onset of labor. The biopsies from the post partal
(PP) women were taken after a normal vaginal delivery.
For the immunohistochemistry study of GR and NFκB,
cervical biopsies were obtained from one para and eleven
primipara TP women (n = 12) with a mean age (range) of
33 (28–38) years, and a mean gestational age of 38 (37 to
40) weeks. The women of the PP group (n = 14) were allReproductive Biology and Endocrinology 2004, 2:74 http://www.rbej.com/content/2/1/74
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primipara and had a mean age of 31 (22–37) years, and a
gestational age of 40 (39 to 42) weeks. The NP control
group (n = 8) had a mean age of 43 (32–49) years, and a
mean parity of II (I-III).
The cervical samples available for the immunohistochem-
istry studies of COX-1, COX-2 and PAF-R were TP (n = 8),
PP (n = 10) and NP group (n = 6). Biopsies for RNA prep-
arations were not available for the RT-PCR study from all
subjects, NP (n = 5), TP (n = 6) and PP (n = 5). The
women in the NP group were significantly older than
those of the other two groups. Since hysterectomies in
young women are uncommon most biopsies in the NP
group are from women in the middle of their 40s, but they
were all menstruating regularly and did not receive any
medication.
Tissue collection
Cervical biopsies were obtained transvaginally (for the TP
and PP groups) from the anterior cervical lip at the 12
o'clock position, from 10–20 mm depth. The tissue sam-
ples from the hysterectomies were obtained directly after
the uterus was removed during operation. The same phy-
sician (YSV) collected all the samples. The biopsies were
immersion-fixed in 4% phosphate buffered formaldehyde
at 4°C overnight, stored at 4°C in 70% ethanol and there-
after embedded in paraffin. From the biopsies that were
large enough, a small piece was cut off prior to fixation,
and frozen in -70°C until RNA preparation.
RNA preparation and reverse transcription
Total RNA from frozen cervical tissue samples was puri-
fied with the SV Total RNA isolation system (Promega,
Madison, WI) according to a procedure recommended by
manufacturer. One microgram of total RNA from each
sample was reverse transcribed at 42°C for 45 min in a
final volume of 40 µl with a reaction mixture containing
50 mmol/l Tris-HCl (pH 8.3), 75 mmol/l KCl, 3 mmol/l
MgCl2, 7.5 mmol/l dithiothretiol, 0.5 mmol dNTPs, 1 µg
random hexameters, and 400 U of Moloney murine
leukemia virus reverse transcriptase (Gibco-BRL, Paisley,
UK).
RT-PCR
Oligonucleotide primers for the GRα gene were as follows
[30]: 5'-CCT AAG GAC GGT CTG AAG AGC-3' and 5'-
GCC AAG TCT TGG CCC TCT AT-3', corresponding to
nucleotides 2158-2178 and 2616-2635 of the human
GRα cDNA (GenBank accession No X03225). Oligonucle-
otide primers for the GRβ gene were as follows [30]: 5'-
CCT AAG GAC GGT CTG AAG AGC-3' and 5'-CCA CGT
ATC CTA AAA GGG CAC-3', corresponding to nucleotides
2158-2178 and 2503-2523 of the human GRβ cDNA
(GenBank accession No X03348). Oligonucleotide prim-
ers for the COX-1 gene were as follows: 5'-TGC CCA GCT
CCT GGC CCG CCG CTT-3' and 5'-GTG CAT CAA CAC
AGG CGC CTC TTC-3', corresponding to nucleotides 568-
591 and 871-847 of the human COX-1 cDNA [31]. Oligo-
nucleotide primers for the COX-2 gene were as follows: 5'-
TTC AAA TGA GAT TGT GGG AAA ATT GCT-3' and 5'-
AGA TCA TCT CTG CCT GAG TAT CTT-3', corresponding
to nucleotides 574-601 and 878-854 of the human COX-
2 cDNA [32]. The predicted size of the PCR products was
477 bp for GRα, 366 bp for GRβ, 304 bp for COX-1 and
305 bp for COX-2.
For PCR, the cDNAs corresponding to 50 ng RNA were
added to 10 µl of HotStarTaq®  master mix (Quiagen
GmbH, Hilden, Germany) containing 2.5 µM of each oli-
gonucleotide primer in a final volume of 20 µl. The reac-
tion mixture was overlaid with mineral oil. After an initial
incubation for 15 min at 95°C, the samples were sub-
jected to 33 (GRα, COX-1 and COX-2) and 40 (GRβ)
cycles of 30 s at 94°C, 40 s at 60°C, and 60 s at 72°C with
a final extension step at 72°C for 10 min in the DNA Ther-
mal Cycler 480 (Perkin-Elmer, Norwalk, CT). The amount
of PCR product for GRα increased linearly up to 36 cycles
and for COX-1 and COX-2 it increased linearly up to 38
cycles (data not shown). Quantitative measurement of
GRβ mRNA would require larger amounts of cervical RNA
than were available, since GRβ showed very low expres-
sion with a visible band only after 40 cycles.
To standardize the quantification method, an endog-
enous 18S rRNA was used as an internal standard. The 18S
rRNA primers and Competimers™ (modified at their 3'
ends to block extension by DNA polymerase) were
obtained from Ambion (Quantum RNA 18S Internal
Standards; Ambion Austin, TX). The standard, and the GR
and COX mRNAs were amplified in parallel and under the
same conditions. A mixture of 18S primers and Compe-
timers™ (1:9) was used to modulate amplification effi-
ciency of 18S rRNA to the same linear range as GRα, COX-
1 and COX-2 when amplified under the same conditions.
The predicted size of the PCR product for 18S was 489 bp.
The PCR products were run on 2% agarose gel and stained
with ethidium bromide. Bands were captured and ana-
lyzed using ChemiDoc Gel Documentation System (Bio-
Rad Laboratories, Hercules, CA). The levels of GR and
COX PCR products were normalized against the 18S prod-
uct. The RT-PCRs were repeated twice.
Immunohistochemistry
Paraffin sections (5 µm) were used and a standard immu-
nohistochemical technique (avidin-biotin-peroxidase)
was carried out as described before [33] to visualize GR,
NFκB, COX-1, COX-2, PAF-R and iNOS. After the tissues
were dewaxed and rehydrated, an antigen retrieval proce-
dure was performed. The sections were pre-treated by
heating in a microwave oven at 700 W in 0.01 M sodiumReproductive Biology and Endocrinology 2004, 2:74 http://www.rbej.com/content/2/1/74
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citrate buffer (pH 6.0). Endogenous peroxidase activity
was blocked by incubation with 3% hydrogen peroxide.
All tissue sections were exposed to a non-immune block
with normal goat serum. A polyclonal rabbit anti-human
antibody was used for the detection of GR (ABR PAI-
511A, Affinity Bioreagents, Inc., Golden, CO, USA). This
antibody recognizes both GRα and GRβ. The tissue sec-
tions were incubated over night in +4°C with the primary
antibody diluted 1:1000. A polyclonal rabbit anti-human
antibody (DB033 Delta Biolabs, Cambell, CA, USA) was
used for the NFκB immunostaining. The tissue sections
were incubated with the primary antibody diluted 1:500
over night at +4°C. The primary antibodies were replaced
with non-immune rabbit IgG in negative controls. Poly-
clonal goat anti-human (sc-1752 and sc-1745, Santa
Cruz) antibodies were used (diluted 1:100) for the COX-
1 and COX-2 respectively. The incubation with primary
antibody was 1 hr at 37°C for both COX-1 and COX-2. A
polyclonal goat anti-human (sc-8741, Santa Cruz) anti-
body was used for the PAF-R immunostaining. The tissue
sections were incubated with the primary antibody
diluted 1:100 over night at +4°C.
Replacing the primary antibody with non-immune goat
IgG was used as negative control.
A monoclonal mouse anti-iNOS antibody was used for
detection of iNOS (N32020, Transduction Laboratories,
Lexington, KY, USA). It recognizes the C-terminal domain
of iNOS. The antibody was diluted 1:50 and incubated for
70 minutes in room temperature. Replacing the primary
antibody with non-immune mouse IgG was used as nega-
tive control.
Image analysis
A microscope and CCD video camera connected to a com-
puter with an image analysis program (Leica Imaging Sys-
tem Ltd., Cambridge, UK) was used to assess quantitative
values from GR and NFκB immunohistochemistry. The
quantification of nuclear immunostaining was performed
on the digitized images of systematic randomly selected
fields of stroma and squamous epithelium. Ten fields
were analyzed separately in each section of tissue, using
the color-discrimination software. Positive staining is pre-
sented as a ratio of the area of positively stained nuclei
(brown) to the total area of cell nuclei (brown and blue).
Manual scoring
Two observers blinded to the identity of the slides, per-
formed all the assessments. The staining was evaluated
semi-quantitatively using a grading system. The staining
intensity was graded on a scale of (0) no staining, (1) very
faint, (2) faint, (3) moderate and (4) strong staining.
Statistics
Statistical calculations for the data from the relative quan-
tification of RT-PCR products, the immunohistochemistry
results by image analysis and manual scoring were per-
formed by ANOVA on Ranks (Kruskal-Wallis' test) and
significances were evaluated by Dunn's test. Values with
different letter designations are significantly different (p <
0.05).
Results
GR
By immunohistochemistry the GR protein was localized
to the nuclei of cervical stroma (S), squamous epithelium
(SQ), glandular epithelium (GE) and vascular endothe-
lium (Figure 1a,1b,1c,1d,1e,1f,1g,1h,1i) in samples from
the NP (left column), TP (middle column) and PP (right
column) groups. By image analysis the GR levels were
determined in SQ and stroma (Figure 2). The stromal cells
include vascular epithelium and the leukocytes within the
stroma. Blood cells within vessels (V) are excluded from
the image analysis. Strong immunostaining was present in
SQ, particularly in the basal and parabasal cell layers (Fig-
ure 1a,1b,1c). There was a significant decrease in immu-
nostaining of the PP group as compared to the TP group,
both in stroma and SQ (Figure 2). The stromal GR immu-
nostaining was increased in the TP group as compared to
the NP and PP groups (Figure 2). It was noted in all
groups that GE (Figure 1g and 1i), vascular endothelium
(Figure 1d,1e and 1f) and some intravascular and perivas-
cular leukocytes (as identified by their morphology, black
arrowheads, Figure 1d and 1f) stained positive for GR,
while some leukocytes were negative (white arrowheads,
Figure 1d and 1f).
NFκB
Positive NFκB immunostaining in cervix uteri was present
in stroma, GE, SQ and vascular endothelium in NP (left
column), TP (middle column) and PP (right column)
groups (Figure 3a,3b,3c,3d,3e,3f,3g,3h,3i,3j,3k,3l).
Strong positive staining for NFκB was also seen in neuro-
nal ganglions (G, Figure 3h) and in smooth muscle cells/
activated fibroblasts, both around blood vessels (Figure
3j) and within the stroma (Figure 3l). In GE the nuclear
and cytoplasmatic NFκB immunostaining was increased
in the PP group as compared to the NP group (Figure 4).
No changes in NFκB staining were observed in SQ (Figure
4). The stroma displayed an increased nuclear immunos-
taining, but unchanged cytoplasmatic staining, in the PP
group as compared to the other groups (Figure 5). Vascu-
lar endothelium showed an increased nuclear but
unchanged cytoplasmatic staining, in the PP group as
compared to the NP group (Figure 5). In all groups some
leukocytes (black arrowhead, Figure 3l), stained positive
for NFκB. As for image analysis of GR, the manual scoringReproductive Biology and Endocrinology 2004, 2:74 http://www.rbej.com/content/2/1/74
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of NFκB in stromal cells could include leukocytes within
the stroma, but not blood cells within vessels.
COX-1
Immunostaining for COX-1 (Figure 6a,6b,6c) was found
in platelets (not shown), some leukocytes (not shown),
vessel endothelium (Figure 6a,6c), stroma (Figure
6a,6b,6c), neuronal ganglion (not shown), SQ (Figure 6c)
and GE (not shown). Manual scoring was performed and
there was a significant increase of COX-1 staining in the
stroma of the TP and PP groups as compared to the NP
group (Figure 7, top). No differences were found in stain-
ing of the SQ, GE and endothelium between the three
groups (data not shown).
COX-2
Immunostaining of COX-2 (Figure 6d,6e,6f,6g,6h,6i) was
found in the stroma, GE and smooth muscle cells/acti-
vated fibroblasts, both around vessels and arranged as
bundles within the stroma. The intensity of COX-2 stain-
ing was overall less than that of COX-1, except in GE
where the immunostaining was almost maximal in all
samples of the TP and PP groups (Figure 6h,6i). There was
Immunostaining of GR in the non-pregnant (NP) (left column, a, d, g), term pregnant (TP) (middle column, b, e, h) and post- partum (PP) (right column, c, f, i) groups Figure 1
Immunostaining of GR in the non-pregnant (NP) (left column, a, d, g), term pregnant (TP) (middle column, b, e, h) and post-
partum (PP) (right column, c, f, i) groups. GR protein (brown staining) is present in the nuclei of cervical stroma (S), squamous 
epithelium (SQ), vessels (V) and glandular epithelium (GE) in all three groups. Some leukocytes, identified by their morphology, 
were positive for GR (black arrowheads) while others were negative (white arrowheads) (d and f). A negative control where 
the primary antibody was replaced by rabbit IgG is shown in h.Reproductive Biology and Endocrinology 2004, 2:74 http://www.rbej.com/content/2/1/74
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GR levels, as assessed by image analysis of immunohistochemistry results, in cervical squamous epithelium (SQ) and stroma in  samples from TP (n = 12) and PP (n = 14) as compared to NP (n = 8) women Figure 2
GR levels, as assessed by image analysis of immunohistochemistry results, in cervical squamous epithelium (SQ) and stroma in 
samples from TP (n = 12) and PP (n = 14) as compared to NP (n = 8) women. Box and whisker plots represent the median 
value with 50% of all data falling within the box. The "whiskers" extend to the 5th and 95th percentiles. Boxes with different let-
ter designations are significantly different, p < 0.05.
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an increased immunostaining in the stroma of the PP
group and in GE from the TP and PP groups, as compared
to the NP group (Figure 7 middle and bottom,
respectively).
Immunostaining of NFκB protein in stroma (S), glandular epithelium (GE), squamous epithelium (SQ) and vessels (V) in cervical  biopsies from the NP (left column, a, d, g, j), TP (middle column, b, e, h) and PP (right column, c, f, i, l) groups Figure 3
Immunostaining of NFκB protein in stroma (S), glandular epithelium (GE), squamous epithelium (SQ) and vessels (V) in cervical 
biopsies from the NP (left column, a, d, g, j), TP (middle column, b, e, h) and PP (right column, c, f, i, l) groups. Positive 
nuclear and cytoplasmic immunostaining is also observed in neuronal ganglions (G) (h). Some leukocytes, identified by their 
morphology, display positive NFκB staining (l, black arrowhead). A negative control where the primary antibody is replaced by 
rabbit IgG is shown in k.Reproductive Biology and Endocrinology 2004, 2:74 http://www.rbej.com/content/2/1/74
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PAF-R
Immunostaining of PAF-R was found in stroma, neuronal
ganglion (G) and GE (Figure 6j,6k,6l,6m,6n). The immu-
nostaining in the stroma was higher in the TP group
(Figure 6k) compared with NP (Figure 6j) and PP groups
(Figure 6l) (Figure 8 top). The immunostaining in GE was
increased in the PP group (Figure 6l) as compared to the
TP group (Figure 6k) (Figure 8 bottom). A negative con-
trol representative for the goat-derived antibodies, where
goat IgG replaced the primary antibody, is shown in Fig-
ure 6o.
iNOS
Faint positive staining was found in SQ, stroma and GE
(Figure 6p,6r). There were no differences in immunostain-
ing of iNOS found between the groups (data not shown).
A negative control where the primary antibody was
replaced by mouse IgG is shown in Figure 6q.
GRα mRNA
The GRα mRNA level was determined by RT-PCR (Figure
9). GRα mRNA levels were not significantly different
between the three study groups, but there was a tendency
of an increased level in the TP group as compared to the
other two groups (Figure 9a). When the relative GRα
mRNA level in the NP group was defined to 100%, the TP
group showed 120% and the PP group 90% of that level.
GRβ mRNA
Very low levels of GRβ mRNA were present in 4 out of 6
samples from the TP group, and in 2 out of 5 samples in
the NP and PP groups (Figure 9b).
NFκB protein levels, as assessed by manual scoring of immunohistochemistry results, in nuclei and cytoplasma of glandular epi- thelium (GE) and squamous epithelium (SQ) in cervical samples from TP (n = 10) and PP (n = 10) as compared to NP (n = 8)  women Figure 4
NFκB protein levels, as assessed by manual scoring of immunohistochemistry results, in nuclei and cytoplasma of glandular epi-
thelium (GE) and squamous epithelium (SQ) in cervical samples from TP (n = 10) and PP (n = 10) as compared to NP (n = 8) 
women. Box and whisker plots represent the median value with 50% of all data falling within the box. The "whiskers" extend to 
the 5th and 95th percentiles. Boxes with different letter designations are significantly different, p < 0.05.Reproductive Biology and Endocrinology 2004, 2:74 http://www.rbej.com/content/2/1/74
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COX-1 mRNA
There was no difference in the COX-1 mRNA level
between the groups, as assessed by RT-PCR (Figure 9c)
(Figure 10, top).
COX-2 mRNA
The COX-2 mRNA level was the highest in the PP group
(Figure 9c) (Figure 10, bottom), but there was a great var-
iation between the individual PP patients (Figure 9c),
probably due to the different amount of glands present in
the biopsies.
Discussion
This study is, to our knowledge, the first reporting GR
expression in human cervix uteri during pregnancy and at
parturition. In a recent study on human endometrium
[34], GR protein was observed in stromal cells and within
leukocytes invading the stroma. Pujols et al. [13] reported
that the expression of GRα mRNA is 400-fold higher than
GRβ mRNA expression in human tissues. The GRα pro-
tein was found in all cells and specimens in their study,
while GRβ was not detected in any specimen. In our study,
GRα mRNA was much more abundant than GRβ mRNA.
Therefore, we conclude that GRα is the major receptor
type observed in our study, although GRβ could contrib-
ute to the GR protein level in the TP group.
Glucocorticoids exert their anti-inflammatory effects pri-
marily by inhibiting the expression of cytokines e.g. IL-8,
as demonstrated in human fibroblasts [35], tumour
necrosis factor (TNF)-α [36], colony-stimulating factor
(CSF) and macrophage stimulating factor (M-CSF) [5].
NFκB protein levels, as assessed by manual scoring, in nuclei and cytoplasma of stroma and vascular endothelium in cervical  samples from TP (n = 10) and PP (n = 10) as compared to NP (n = 8) women Figure 5
NFκB protein levels, as assessed by manual scoring, in nuclei and cytoplasma of stroma and vascular endothelium in cervical 
samples from TP (n = 10) and PP (n = 10) as compared to NP (n = 8) women. Box and whisker plots represent the median 
value with 50% of all data falling within the box. The "whiskers" extend to the 5th and 95th percentiles. Boxes with different let-
ter designations are significantly different, p < 0.05.Reproductive Biology and Endocrinology 2004, 2:74 http://www.rbej.com/content/2/1/74
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Immunostaining of COX-1 (a-c), COX-2 (d-i), PAF-R (j-n) and iNOS (p, r), in cervices from women in the NP (left column),  TP (middle column) and PP (right column) group Figure 6
Immunostaining of COX-1 (a-c), COX-2 (d-i), PAF-R (j-n) and iNOS (p, r), in cervices from women in the NP (left column), 
TP (middle column) and PP (right column) group. A representative negative control for COX-1, COX-2 and PAF-R immuno-
histochemistry (primary antibody replaced by goat IgG, same secondary antibody) is shown in o, the negative control for iNOS 
is shown in q (primary antibody replaced by mouse IgG). Abbreviations: S = stroma, GE = glandular epithelium, SQ = squa-
mous epithelium, V = vessel and G = ganglion cells.Reproductive Biology and Endocrinology 2004, 2:74 http://www.rbej.com/content/2/1/74
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COX-1 (top) and COX-2 (middle, bottom) protein levels, as assessed by manual scoring of stroma (top, middle) and glandular  epithelium (bottom) in cervical samples from the TP (n = 8), PP (n = 9) and NP (n = 6) groups Figure 7
COX-1 (top) and COX-2 (middle, bottom) protein levels, as assessed by manual scoring of stroma (top, middle) and glandular 
epithelium (bottom) in cervical samples from the TP (n = 8), PP (n = 9) and NP (n = 6) groups. Box and whisker plots repre-
sent the median value with 50% of all data falling within the box. The "whiskers" extend to the 5th and 95th percentiles. Boxes 
with different letter designations are significantly different, p < 0.05.Reproductive Biology and Endocrinology 2004, 2:74 http://www.rbej.com/content/2/1/74
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The majority of these pro-inflammatory genes have no
glucocorticoid responsive elements (GRE) in their
promoter regions that could explain the effect of
glucocorticoids, but many of them contain sites for the
transcription factors activating protein (AP)-1 and NFκB
[37]. In the review by McKay and Cidlowski [[5], and ref-
erences therein] it is obvious though, after comparing the
genes transcriptionally regulated by NFκB (e.g. IL-8,
PAF-R protein levels, as assessed by manual scoring, in stroma (top) and glandular epithelium (bottom) in cervical samples from  the TP (n = 11), PP (n = 13) and NP (n = 9) groups Figure 8
PAF-R protein levels, as assessed by manual scoring, in stroma (top) and glandular epithelium (bottom) in cervical samples from 
the TP (n = 11), PP (n = 13) and NP (n = 9) groups. Box and whisker plots represent the median value with 50% of all data fall-
ing within the box. The "whiskers" extend to the 5th and 95th percentiles. Boxes with different letter designations are signifi-
cantly different, p < 0.05.Reproductive Biology and Endocrinology 2004, 2:74 http://www.rbej.com/content/2/1/74
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Images of representative RT-PCR gels for a: GRα, b: GRβ and c: COX-1 (upper band) and COX-2 (middle band) in the human  cervix in the non-pregnant (NP; n = 5), term pregnant (TP; n = 6) and postpartum (PP; n = 5) groups Figure 9
Images of representative RT-PCR gels for a: GRα, b: GRβ and c: COX-1 (upper band) and COX-2 (middle band) in the human 
cervix in the non-pregnant (NP; n = 5), term pregnant (TP; n = 6) and postpartum (PP; n = 5) groups. The gels are stained with 
ethidium bromide. a: GRαmRNA(upper band) and 18S mRNA (lower band). b: 18S mRNA (upper band) and GRβm-
RNA(lower band). c: The 18S mRNA (bottom band) and the COX-1 (upper band) and COX-2 (middle band) PCR products.
a .
.
.Reproductive Biology and Endocrinology 2004, 2:74 http://www.rbej.com/content/2/1/74
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iNOS, COX-2) and genes repressed by GR (e.g. IL-8, iNOS,
COX-2, GR, CRH, fibronectin, and metalloproteinases
(MMPs)), that NFκB and GR have diametrically opposed
functions. The oppositely regulated IL-8, iNOS and COX-
2 have all proven to be important for cervical ripening and
labor induction [4,17,38].
Maternal plasma levels of cortisol increase until term [6],
but their diurnal variation is maintained [39] although
more long-term variations have been suggested [40]. At
parturition, maternal plasma levels of placental CRH
[10,41], pituitary adrenocorticotropic hormone (ACTH)
and adrenal cortisol [6] increase exponentially.
COX-1 (top) and COX-2 (bottom) mRNA levels in the human cervix from the NP (n = 5), the TP (n = 6) and the PP (n = 5)  groups as determined by RT-PCR Figure 10
COX-1 (top) and COX-2 (bottom) mRNA levels in the human cervix from the NP (n = 5), the TP (n = 6) and the PP (n = 5) 
groups as determined by RT-PCR. Intensities of the PCR product bands were normalized against the internal 18S standard. 
Box and whisker plots represent the median value with 50% of all data falling within the box. The whiskers extend to the 5th 
and 95th percentiles. Group medians with different letter superscripts are significantly different (P < 0.05).Reproductive Biology and Endocrinology 2004, 2:74 http://www.rbej.com/content/2/1/74
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Our data shows that the GR protein was present in cervical
stroma, SQ and vascular endothelium in samples from
non-pregnant, term pregnant and postpartum women.
The decrease in GR levels in stroma and SQ at parturition,
as compared to term, could be interpreted in terms of a
GR mediated glucocorticoid anti-inflammatory activity
during pregnancy that is ended at parturition.
The NFκB protein was present in cervices from non-preg-
nant, term pregnant and postpartum women. This pro-
tein, ubiquitously expressed in a variety of cell types, is
found in the cytoplasm in its inactive form, but
translocates into the nucleus upon activation [14]. There-
fore, the increase in nuclear NFκB levels in cervical
stroma, GE and vascular endothelium in the PP group
suggests an activation of NFκB at parturition. Thus, our
present results of decreased GR and increased NFκB levels
at parturition are in agreement with the reports of their
opposed effects on the activity of several inflammatory
genes [[5], and references therein] and the idea of cervical
ripening being an inflammatory reaction [42].
Polymorphonuclear leukocytes and macrophages migrate
from blood vessels and accumulate in the cervix uteri
before parturition [2]. GR and NFκB were identified by
immunohistochemistry in morphologically recognized
leukocytes in the samples from all groups in this study.
GR-positive leukocytes have also been observed in the
endometrium of non-pregnant women and the decidua of
early pregnant women [43].
Cortisol is a potent inhibitor of COX-2 in myometrium,
decidua and cervix [[17], and references therein]. We
found the constitutive COX-1 protein to be present at
higher levels in the stroma at term and postpartum,
whereas COX-1 mRNA was unchanged. Inducible COX-2
mRNA was increased at parturition as compared to term,
and the COX-2 protein was increased in stroma postpar-
tum and in GE at term and postpartum as compared to the
NP group. Our observations suggest, that prostaglandin
synthesis occur especially in the GE, where a highly inten-
sive COX-2 immunostaining was observed at term and
postpartum. This is in agreement with a recent report on
COX-2 mRNA in the pregnant baboon cervix [44]. This
would also explain the large variation in COX-2 mRNA
levels found in the present study. The RNA is prepared
from homogenates of cervical biopsies, and the amount
of glands present in the biopsies varies from none to
plenty. Our results indicate that prostaglandin synthesis
could be regulated predominantly via COX-2 in cervical
GE at parturition. The stromal increase in COX enzymes
could be due to the influx of macrophages and leukocytes
before parturition [2], since leukocytes are an abundant
source of PGE2 in the human body [45]. We could not
exclude that COX-1 and COX-2 are present in the stromal
cells, thereby adding another cervical source of prostag-
landin synthesis, but it seems likely that the enzymes are
mainly expressed in the invading leukocytes. Further, our
data together with previous findings, suggest suppression
not only by progesterone [46], but also by cortisol [[17],
and references therein] of prostaglandin synthesis in the
human uterine cervix during pregnancy and a release of
this suppression at parturition. Since the COX-2 promoter
contains NFκB binding sites [47], the activation of COX-2
could be regulated via NFκB.
Nitric oxide stimulates PGE2 release from human cervical
tissue explants [23]. Nitric oxide donors induce cervical
ripening in term pregnancy in humans [28]. Treatment
with the NO donor isosorbid-5-mononitrate stimulates
the synthesis of COX-2 and PGE2 in human uterine cervix
[27]. The immunostaining of iNOS in the present study
did not differ between the groups, and thus did not vary
due to pregnancy or parturition. This is not in agreement
with previous studies on human cervix [38,48]. Tschug-
guel et al. found increased iNOS immunostaining with an
antibody from Transduction laboratories (no number
stated), but not on the mRNA level using RT-PCR, indicat-
ing a post-transcriptional regulation of iNOS [38]. Led-
ingham et al. [48] found increased cervical
immunostaining and stronger bands on Western blot in
term pregnancy as compared to the non-pregnant state,
using an antibody from Transduction laboratories
(39120, clone 54). We also used a monoclonal iNOS anti-
body from Transduction laboratories, but a different
clone (32020, clone 6), which could explain the different
results. We found some staining in GE, while Ledingham
et al. state no staining of the glands [48].
Platelet activating factor (PAF), like prostaglandins
derived from the arachidonic acid precursor, is a
multifactorial pro-inflammatory mediator, which has
been implicated in parturition. Local application of PAF
in rats induced cervical ripening [49], whereas a PAF-R
antagonist prolonged parturition [50]. PAF-R has been
identified in human cervical fibroblasts in vitro [51]. We
show, for the first time, presence of the PAF-R protein in
the human uterine cervix in vivo. Stromal PAF-R immu-
nostaining was most pronounced at term, and decreased
after parturition. PAF-R immunostaining was, like for
COX-2, further increased in GE postpartum. PAF increases
the expression of pro-inflammatory cytokines e.g. IL-8,
and this effect can be abolished using a PAF-R antagonist
(WEB2170) [18,51]. Furthermore, the COX-2 promoter
contains NFκB binding sites [47], and the PAF stimulated
COX-2 induction is NFκB dependent [51], indicating that
the PAF-R could activate NFκB and thereby induce COX-
2. PAF also increases expression of MMP-1 [51], which has
been shown to effectuate collagen degradation and cervi-
cal ripening [1,52].Reproductive Biology and Endocrinology 2004, 2:74 http://www.rbej.com/content/2/1/74
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If the process of cervical ripening is disturbed, either
resulting in a preterm delivery or to a prolonged delivery
time, possibly ended by a cesarean section, it will lead to
increased risks for both the mother and the child. Preterm
delivery is the leading factor causing neonatal mortality
and morbidity [54]. An increased knowledge of the factors
regulating the cervical ripening process will give tools for
developing pharmaceuticals that can regulate cervical
ripening.
Conclusions
We have demonstrated that the human uterine cervix is a
potential target organ for glucocorticoids during preg-
nancy. The higher GR protein levels in cervical stroma and
SQ before parturition may reflect a GR mediated anti-
inflammatory effect of cortisol during pregnancy, with a
subsequent decline of this activity at parturition. The con-
comitant increase in nuclear NFκB levels in the cervix sug-
gests activation of this transcription factor at parturition.
NFκB activity promotes pro-inflammatory events and
could be responsible, at least in part, for the observed
increase in COX-1, COX-2 and PAF-R levels.
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